Cryoport (CYRX) Fundamental Analysis: Revenue, Earnings & Valuation

0.51 / 10

Underperform

Fundamental analysis rates CYRX as Underperform, scoring 0.5/10. Revenue‑MV and Cash‑MV are negative, while Profit‑MV is modestly positive. Asset‑MV and ROA are average. Overall, the quality metrics suggest a challenging financial profile.

Analysis Checks(6/10)

Revenue-MV

Value-0.52

Score0/3

Weight92.61%

1M Return-4.18%

ROA (%)

Value10.66

Score2/3

Weight-17.07%

1M Return0.64%

Net cash flow from operating activities / Operating revenue (%)

Value-4.87

Score1/3

Weight30.44%

1M Return-1.35%

Profit-MV

Value1.83

Score2/3

Weight-87.47%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value10.66

Score2/3

Weight-17.07%

1M Return0.64%

EBIT / Total operating revenue (%)

Value-16.92

Score2/3

Weight-2.62%

1M Return0.10%

Asset-MV

Value-0.55

Score2/3

Weight-14.96%

1M Return0.57%

Net profit / Total operating revenue (%)

Value44.44

Score1/3

Weight19.66%

1M Return-0.84%

Cash-MV

Value-2.97

Score1/3

Weight82.92%

1M Return-4.16%

Net profit / Total profit (%)

Value-243.40

Score2/3

Weight13.55%

1M Return-0.54%

Is CYRX fundamentally strong?

CYRX scores 0.51/10 on fundamentals and holds a Premium valuation at present. Backed by its 15.54% ROE, 44.44% net margin, 6.04 P/E ratio, 0.84 P/B ratio, and 156.22% earnings growth, these metrics solidify its Underperform investment rating.